ScholarIQanswers from OpenAlex
DRK Kliniken Berlin
InstitutionResearch output, impact & collaborations
DRK Kliniken Berlin is a institution indexed in ScholarIQ from OpenAlex.
What is known about DRK Kliniken Berlin?
ScholarIQrecord summary
DRK Kliniken Berlin is a research organisation in Berlin, DE. OpenAlex records 2,575 works and 91,389 citations for it. 688 researchers list it as their most recent affiliation.
How many works does DRK Kliniken Berlin have?
ScholarIQindexed works
DRK Kliniken Berlin has 2,575 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does DRK Kliniken Berlin have?
ScholarIQcitation count
DRK Kliniken Berlin has 91,389 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at DRK Kliniken Berlin?
ScholarIQresearcher count
DRK Kliniken Berlin has 688 researchers in the ScholarIQ index.
What is the average h-index at DRK Kliniken Berlin?
ScholarIQavg h-index
DRK Kliniken Berlin has an average h-index of 68.3 in OpenAlex.
What is the ROR of DRK Kliniken Berlin?
ScholarIQror
The ROR for DRK Kliniken Berlin is on the source record.
What is the OpenAlex record for DRK Kliniken Berlin?
ScholarIQopenalex
The OpenAlex for DRK Kliniken Berlin is on the source record.
Who are the most-cited researchers behind DRK Kliniken Berlin?
ScholarIQtop researchers by citations
What are the most-cited papers on DRK Kliniken Berlin?
ScholarIQmost cited works
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
Yi‐Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohé, Margarita Majem, Jonathan W. Goldman, К. К. Лактионов, Sang‐We Kim, Terufumi Kato, Huu-Vinh Vu, Shun Lü, Kye Young Lee, Charuwan Akewanlop, Chong‐Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Dómine, Frances A. Shepherd, Lingmin Zeng, Rachel Hodge, Ajlan Atasoy, Yuri Rukazenkov, Roy S. Herbst
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi, Julien Mazières, David Planchard, Thomas E. Stinchcombe, Grace K. Dy, Scott Antonia, Leora Horn, H. Léna, Elisa Minenza, B. Mennecier, Gregory A. Otterson, Luis T. Campos, David R. Gandara, Benjamin Levy, Suresh Nair, Gérard Zalcman, Jürgen Wolf, Pierre‐Jean Souquet, Editta Baldini, Federico Cappuzzo, C. Chouaïd, Afshin Dowlati, Rachel E. Sanborn, Ariel López-Chávez, Christian Grohé, Rudolf M. Huber, Christopher Harbison, Christine Baudelet, Brian Lestini, Suresh S. Ramalingam
Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLC
Masahiro Tsuboi, Roy S. Herbst, Thomas John, Terufumi Kato, Margarita Majem, Christian Grohé, Jie Wang, Jonathan W. Goldman, Shun Lü, Wu‐Chou Su, Filippo de Marinis, Frances A. Shepherd, Ki Hyeong Lee, Nhieu Thi Le, Arunee Dechaphunkul, Dariusz M. Kowalski, Lynne Poole, Ana Bolanos, Yuri Rukazenkov, Yi‐Long Wu
Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers
Marius M. Hoeper, Stephen H. Lee, Robert Voswinckel, Massimiliano Palazzini, Xavier Jaïs, Alessandro Marinelli, Robyn J. Barst, Hossein Ardeschir Ghofrani, Zhi‐Cheng Jing, Christian Opitz, Hans-Juergen Seyfarth, Michael Halank, Vallerie V. McLaughlin, Ronald J. Oudiz, Ralf Ewert, Heinrike Wilkens, Stefan Kluge, Hinrich-Cordt Bremer, Eva Baroke, Lewis J. Rubin
Assessment of Survival in Patients With Primary Pulmonary Hypertension
Roland Wensel, Christian Opitz, Stefan D. Anker, Jörg Winkler, G. Höffken, Franz X. Kleber, Rakesh Kumar Sharma, Manfred Hummel, Roland Hetzer, Ralf Ewert
How much of the research on DRK Kliniken Berlin is open access?
ScholarIQopen access share
75%OPEN ACCESS